Tech Company Financing Transactions
Neuromed Pharmaceuticals Funding Round
MPM Capital invested in a $25 million Series D funding round for Neuromed Pharmaceuticals. The round was announced on 3/8/2006.
Transaction Overview
Company Name
Announced On
3/8/2006
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series D
Investors
Proceeds Purpose
Neuromed will use the funds to advance its lead program for developing calcium channel blockers for chronic pain, as well as for its second major development program investigating calcium channel blockers to treat pain, anxiety, epilepsy and cardiovascular diseases.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Six Tower Bridge 181 Washington Street 440
Conshohocken, PA 19428
USA
Conshohocken, PA 19428
USA
Phone
Website
Email Address
Overview
Neuromed is a privately held biopharmaceutical company developing the next generation of chronic pain drugs with pipeline programs in anxiety, epilepsy and cardiovascular disease such as hypertension.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Gallen
Chief Financial Officer
Bruce Colwill
Chief Scientific Officer
Terrance Snutch
Vice President
Simon Li
Vice President
Gene Wright
VP - Bus. Development
Jeffrey Arcara
VP - Marketing
Mario Orlando
Browse more venture capital transactions:
Prev: 3/8/2006: ThingMagic venture capital transaction
Next: 3/8/2006: Ikonisys venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs